Pseudoxanthoma elasticum-like skin changes induced by penicillamine

Bentley-Phillips, Barry
September 1985
Journal of the Royal Society of Medicine;Sep1985, Vol. 78 Issue 9, p787
Academic Journal
A letter to the editor is presented in response to a report by Meyrick Thomas regarding the side effects of penicillamine to a male patient suffering from cystinuria in the September 1984 issue.


Related Articles

  • Effect of oral iron on penicillamine absorption. Lyle, W. H. // Journal of the Royal Society of Medicine;Jan1988, Vol. 81 Issue 1, p58 

    A letter to the editor is presented about the effects of oral iron on the absorption of penicillamine.

  • The Mechanisms of Penicillamine, Trientine, and Zinc in the Treatment of Wilson's Disease. Yarze, Joseph Carl // American Journal of Gastroenterology;Jun1995, Vol. 90 Issue 6, p1026 

    Presents a letter to the editor in response to the article "Penicillamine Hypersensitivity: Successful De-sensitization of a Patient With Severe Hepatic Wilson's Disease," by C.-Y. Chan and A. L. Baker," in the 1994 issue.

  • Mechanisms of Pennicillamine and Zinc in the Treatment of Wilson's Disease. Farinati, F.; Cardin, R.; Mestriner, C.; Sturniolo, G. C.; Naecarato, R. // American Journal of Gastroenterology;Dec1995, Vol. 90 Issue 12, p2264 

    Presents letters to the editor referencing articles and topics discussed in previous issues. "Penicillamine Hypersensitivity: Successful Desensitization of Patients With Severe Hepatic Wilson's Disease," which examined hepatic Wilson's disease; "The Mechanisms of Penicillamine, Trientine, and...

  • Penicillamine-induced neuromyotonia. Reeback, Jane; Benton, Sarah; Swash, Michael; Schwartz, Martin S. // British Medical Journal;6/2/1979, Vol. 1 Issue 6176, p1464 

    Presents a case report on penicillamine-induced neuromyotonia. Treatment of rheumatoid arthritis with penicillamine; Association penicillamine treatment of rheumatoid arthritis with polymitosis and myasthenia gravis; Pathogenesis of neuromyotonia.

  • Exacerbation of diazepam-induced phlebitis by oral penicillamine. Brandstetter, Robert D.; Gotz, Vincent P.; Mar, Dexter D.; Sachs, Deane // British Medical Journal (Clinical Research Edition);8/22/1981, Vol. 283 Issue 6290, p525 

    Examines the oral penicillamine in patients with phlebitis in Great Britain. Severity of the reactions to the drug; Toxicity for patients with rheumatoid arthritis; Development of phlebitis from intravenous diazepam.

  • Natural course of penicillamine nephropathy: a long term study of 33 patients. Hall, C.L.; Jawad, S.; Harrison, P.R.; MacKenzie, J.C.; Bacon, P.A.; Klouda, P.T.; MacIver, A.G. // British Medical Journal (Clinical Research Edition);4/16/1988, Vol. 296 Issue 6629, p1083 

    Examines the natural course of the neuropathy associated with penicillamine and the clinical management of patients with rheumatoid arthritis. Conduction of renal biopsies; Measurement of creatinine clearance and proteinuria; Implication of penicillamine treatment for the resolution of the...

  • Penicillamine nephropathy.  // British Medical Journal (Clinical Research Edition);3/7/1981, Vol. 282 Issue 6266, p761 

    Examines the occurence of proteinuria due ti treatment with penicillamine. Comparisons on the occurence of proteinuria in patients with rheumatoid arthritis and Wilson's diseases; Indication of minimal changes according to the histological examination of renal biopsy specimens from affected...

  • Penicillamine-Induced Neuropathy in Rheumatoid Arthritis. Pool, K.D.; Feit, Howard; Kirkpatrick, Joel // Annals of Internal Medicine;Oct81, Vol. 95 Issue 4, p457 

    Presents a case of penicillamine-induced neuropathy in rheumatoid arthritis. Indication of penicillamine in rheumatoid arthritis; Case report on the patient; Discussion on the clinical findings.

  • The toxicity of D-penicillamine in systemic sclerosis. Steen, Virginia D.; Blair, Sandra; Medsger Jr., Thomas A.; Steen, V D; Blair, S; Medsger, T A Jr // Annals of Internal Medicine;May86, Vol. 104 Issue 5, p699 

    We studied D-penicillamine toxicity in 259 patients with systemic sclerosis treated since 1972. The average daily dose of 635 mg was given for a mean of 1.8 years. Of patients with systemic sclerosis, 47% has side effects from D-penicillamine treatment, similar to the 56% of 807 patients with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics